Category: D59 - Acquired hemolytic anemia

 Chapter Notes

 D59

Acquired hemolytic anemia

 D59.0

Drug-induced autoimmune hemolytic anemia

Use additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

 D59.1

Other autoimmune hemolytic anemias

Evans syndrome (D69.41)

hemolytic disease of newborn (P55.-)

paroxysmal cold hemoglobinuria (D59.6)

 D59.10

Autoimmune hemolytic anemia, unspecified

 D59.11

Warm autoimmune hemolytic anemia

Warm type (primary) (secondary) (symptomatic) autoimmune hemolytic anemia

Warm type autoimmune hemolytic disease

 D59.12

Cold autoimmune hemolytic anemia

Chronic cold hemagglutinin disease

Cold agglutinin disease

Cold agglutinin hemoglobinuria

Cold type (primary) (secondary) (symptomatic) autoimmune hemolytic anemia

Cold type autoimmune hemolytic disease

 D59.13

Mixed type autoimmune hemolytic anemia

Mixed type autoimmune hemolytic disease

Mixed type, cold and warm, (primary) (secondary) (symptomatic) autoimmune hemolytic anemia

 D59.19

Other autoimmune hemolytic anemia

 D59.2

Drug-induced nonautoimmune hemolytic anemia

Drug-induced enzyme deficiency anemia

Use additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

 D59.3

Hemolytic-uremic syndrome

Code also, if applicable, any associated:

acute kidney failure (N17.-)

chronic kidney disease (N18.-)

 D59.30

Hemolytic-uremic syndrome, unspecified

Hemolytic-uremic syndrome NOS

 D59.31

Infection-associated hemolytic-uremic syndrome

Shiga toxin-producing E. coli [STEC] related hemolytic uremic syndrome

Typical hemolytic uremic syndrome

Use additional code to identify associated infection, such as :

E. coli infection (B96.2-)

Human immunodeficiency virus [HIV] disease (B20)

Pneumococcal meningitis (G00.1)

Pneumococcal pneumonia (J13)

Sepsis due to Streptococcus pneumoniae (A40.3)

Shigella dysenteriae (A03.9)

Streptococcus pneumoniae as the cause of diseases classified elsewhere (B95.3)

 D59.32

Hereditary hemolytic-uremic syndrome

Atypical hemolytic uremic syndrome with an identified genetic cause

Code also, if applicable:

defects in the complement system (D84.1)

methylmalonic acidemia (E71.120)

 D59.39

Other hemolytic-uremic syndrome

Atypical (nongenetic) hemolytic uremic syndrome

Secondary hemolytic-uremic syndrome

Code first, if applicable, any associated:

COVID-19 (U07.1)

complications of kidney transplant (T86.1-)

complications of heart transplant (T86.2-)

complications of liver transplant (T86.4-)

Code also, if applicable, any associated condition, such as:

hypertensive emergency (I16.1)

malignant neoplasm (C00-C96)

systemic lupus erythematosus (M32.-)

Use additional code, if applicable, for adverse effect to identify drug (T36-T50 with fifth or sixth character 5)

 D59.4

Other nonautoimmune hemolytic anemias

Mechanical hemolytic anemia

Microangiopathic hemolytic anemia

Toxic hemolytic anemia

 D59.5

Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]

hemoglobinuria NOS (R82.3)

 D59.6

Hemoglobinuria due to hemolysis from other external causes

Hemoglobinuria from exertion

March hemoglobinuria

Paroxysmal cold hemoglobinuria

Use additional code (Chapter 20) to identify external cause

hemoglobinuria NOS (R82.3)

 D59.8

Other acquired hemolytic anemias

 D59.9

Acquired hemolytic anemia, unspecified

Idiopathic hemolytic anemia, chronic